 |
|
|
|
|
Once-a-Year Drug Helps Counter Steroid-Linked Bone Loss
|
| | | | Related Healthscout Videos | |
|
Page: << Prev | 1 | 2 | 3 "I think the successful once-a-year use of this long-acting bisphosphonate is perhaps once of the most dramatic events that has occurred in the osteoporosis arena in the last few years," he said. "For a long time, many of us have thought this would prove to be the case, based on our own clinical use, but now it has been demonstrated very clearly, and will be very relevant for all those patients at risk for bone loss and fracture."
More information
Text Continues Below
For more about bone loss, visit the U.S. National Institutes of Health.
Page: << Prev | 1 | 2 | 3
|
Copyright © 2009 ScoutNews, LLC. All rights reserved.
Last updated 4/13/2009
|
|
SOURCES: David M. Reid, M.D., professor, rheumatology, and head, division of applied medicine, University of Aberdeen, Aberdeen, Scotland, U.K.; Mone Zaidi, M.D., Ph.D., professor, medicine and physiology, and director, Mount Sinai Bone Program, Mount Sinai School of Medicine, New York City; April 11, 2009, The Lancet
|
.gif)
